Filing Details
- Accession Number:
- 0001209191-17-049546
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-17 20:36:39
- Reporting Period:
- 2017-08-16
- Filing Date:
- 2017-08-17
- Accepted Time:
- 2017-08-17 20:36:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1438533 | Retrophin Inc. | RTRX | Pharmaceutical Preparations (2834) | 262383102 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1681098 | F. Neil Mcfarlane | C/O Retrophin, Inc. 3721 Valley Centre Dr., Suite 200 San Diego CA 92130 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-16 | 1,378 | $22.50 | 13,622 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.
Billionaire Hedge Funds
